$15.900
-0.789 (-4.96%)At close
- High
- 16.720
- Open
- 16.700
- VWAP
- 16.11
- Vol
- 105.55K
- Mkt Cap
- 205.55M
- Low
- 15.710
- Amount
- 1.70M
- EV/EBITDA, TTM
- 0.00
SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. The Company provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. The Company's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million.
AI analysis of SWK Holdings Corp (SWKH)
sellSWK Holdings Corp (SWKH) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is significantly deteriorating, with revenue, net income, and EPS showing sharp declines. Technical indicators suggest a bearish trend, and there are no positive trading signals or catalysts to support a buy decision. Additionally, there is no recent news, analyst ratings, or insider activity to indicate potential upside.
Valuation Metrics
Events Timeline
News
8.503-09Yahoo FinanceRunway Growth Finance Acquires SWK Holdings to Scale Portfolio
7.010-16PRnewswireSHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders
7.010-16GlobenewswireBRODSKY & SMITH INVESTOR ALERT: Updates on Investigations Involving TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH), and SWK Holdings Corporation (Nasdaq – SWKH)
4.510-15TipRanksVTI ETF Daily Update: Key Information for Investors – 10/15/2025
7.010-11GlobenewswireSHAREHOLDER RIGHTS NOTICE: Halper Sadeh LLC Probes EA, HSII, SWKH for Shareholder Interests
SWKH FAQ — answered by Alphio AI
SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. The Company provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. The Company's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million. It operates in the Financials sector (MISCELLANEOUS BUSINESS CREDIT INSTITUTION industry).
SWK Holdings Corp (SWKH) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is significantly deteriorating, with revenue, net income, and EPS showing sharp declines. Technical indicators suggest a bearish trend, and there are no positive trading signals or catalysts to support a buy decision. Additionally, there is no recent news, analyst ratings, or insider activity to indicate potential upside.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.